BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26297658)

  • 1. COS-STAR: a reporting guideline for studies developing core outcome sets (protocol).
    Kirkham JJ; Gorst S; Altman DG; Blazeby J; Clarke M; Devane D; Gargon E; Williamson PR;
    Trials; 2015 Aug; 16():373. PubMed ID: 26297658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of reporting guidance and core outcome sets for seamless, standardised evaluation of innovative surgical procedures and devices: a study protocol for content generation and a Delphi consensus process (COHESIVE study).
    Avery K; Blazeby J; Wilson N; Macefield R; Cousins S; Main B; Blencowe NS; Zahra J; Elliott D; Hinchliffe R; Potter S
    BMJ Open; 2019 Sep; 9(9):e029574. PubMed ID: 31515426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
    Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
    Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core Outcome Set-STAndards for Reporting: The COS-STAR Statement.
    Kirkham JJ; Gorst S; Altman DG; Blazeby JM; Clarke M; Devane D; Gargon E; Moher D; Schmitt J; Tugwell P; Tunis S; Williamson PR
    PLoS Med; 2016 Oct; 13(10):e1002148. PubMed ID: 27755541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'core outcome set'.
    Prinsen CA; Vohra S; Rose MR; King-Jones S; Ishaque S; Bhaloo Z; Adams D; Terwee CB
    Trials; 2014 Jun; 15():247. PubMed ID: 24962012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Core Outcome Set for Studies on Obesity in Pregnant Patients (COSSOPP): a study protocol.
    Dadouch R; Faheim M; Juando-Prats C; Parsons J; D'Souza R;
    Trials; 2018 Nov; 19(1):655. PubMed ID: 30482249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core Outcome Set-STAndardised Protocol Items: the COS-STAP Statement.
    Kirkham JJ; Gorst S; Altman DG; Blazeby JM; Clarke M; Tunis S; Williamson PR;
    Trials; 2019 Feb; 20(1):116. PubMed ID: 30744706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core Outcome Set for GROwth restriction: deVeloping Endpoints (COSGROVE).
    Healy P; Gordijn S; Ganzevoort W; Beune I; Baschat A; Khalil A; Kenny L; Bloomfield F; Daly M; Papageorghiou A; Devane D
    Trials; 2018 Aug; 19(1):451. PubMed ID: 30134949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Core Outcome Set-STAndards for Development: The COS-STAD recommendations.
    Kirkham JJ; Davis K; Altman DG; Blazeby JM; Clarke M; Tunis S; Williamson PR
    PLoS Med; 2017 Nov; 14(11):e1002447. PubMed ID: 29145404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Chiren SG; Godinez-Puig V; Chen BR; Kurta AO; Schmitt J; Deckert S; Furlan KC; Poon E; Cartee TV; Maher IA; Alam M; Sobanko JF
    Trials; 2017 Jul; 18(1):321. PubMed ID: 28701207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A protocol for the Development of Core Outcome Sets for Endodontic Treatment modalities (COSET): an international consensus process.
    El Karim IA; Duncan HF; Cushley S; Nagendrababu V; Kirkevang LL; Kruse C; Chong BS; Shah PK; Lappin M; McLister C; Lundy FT; Clarke M
    Trials; 2021 Nov; 22(1):812. PubMed ID: 34789318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardising the reporting of outcomes in gastric cancer surgery trials: protocol for the development of a core outcome set and accompanying outcome measurement instrument set (the GASTROS study).
    Alkhaffaf B; Glenny AM; Blazeby JM; Williamson P; Bruce IA
    Trials; 2017 Aug; 18(1):370. PubMed ID: 28793921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
    Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
    BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Handover Core Outcome Measures (SH-CORE): a protocol for the development of a core outcome set for trials in surgical handover.
    Ryan JM; Devane D; Simiceva A; Eppich W; Kavanagh DO; Cullen C; Hogan AM; McNamara DA
    Trials; 2024 Jun; 25(1):373. PubMed ID: 38858749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for the development of the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies.
    Richardson M; Kirkham JJ; Dwan KM; Sloan DJ; Davies G; Jorgensen A
    BMJ Open; 2019 Jul; 9(7):e030212. PubMed ID: 31300508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus study.
    Karnik NS; Campbell CI; Curtis ME; Fiellin DA; Ghitza U; Hefner K; Hser YI; McHugh RK; Murphy SM; McPherson SM; Moran L; Mooney LJ; Wu LT; Shmueli-Blumberg D; Shulman M; Schwartz RP; Stephens KA; Watkins KE; Marsden J
    Trials; 2021 Jan; 22(1):102. PubMed ID: 33509278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an international core outcome set for treatment trials in necrotizing enterocolitis-a study protocol.
    Klerk DH; van Varsseveld OC; Offringa M; Modi N; Lacher M; Zani A; Pakarinen MP; Koivusalo A; Jester I; Spruce M; Derikx JPM; Bakx R; Ksia A; Vermeulen MJ; Kooi EMW; Hulscher JBF
    Trials; 2023 May; 24(1):367. PubMed ID: 37259112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set.
    Chiarotto A; Terwee CB; Deyo RA; Boers M; Lin CW; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
    Trials; 2014 Dec; 15():511. PubMed ID: 25540987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A core outcomes set for clinical trials of interventions for young adults with type 1 diabetes: an international, multi-perspective Delphi consensus study.
    Byrne M; O'Connell A; Egan AM; Dinneen SF; Hynes L; O'Hara MC; Holt RIG; Willaing I; Vallis M; Hendrieckx C; Coyne I
    Trials; 2017 Dec; 18(1):602. PubMed ID: 29258565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 'Outcome Reporting in Brief Intervention Trials: Alcohol' (ORBITAL) framework: protocol to determine a core outcome set for efficacy and effectiveness trials of alcohol screening and brief intervention.
    Shorter GW; Heather N; Bray JW; Giles EL; Holloway A; Barbosa C; Berman AH; O'Donnell AJ; Clarke M; Stockdale KJ; Newbury-Birch D
    Trials; 2017 Dec; 18(1):611. PubMed ID: 29273070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.